However, the absence of a significant difference between grades I–III could indicate that KAT8 expression is not a reliable discriminator for tumour grade in lower‐grade gliomas, pointing to the need for further investigation into its specific role in glioma progression. Here, KAT8 is linked to central nervous system cancer.